![Maj-Britt Kaltoft](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maj-Britt Kaltoft
Corporate Officer/Principal chez
Statens Serum Institute
Profil
Maj-Britt Kaltoft is currently the Head of Business Development & Patent Functions at Statens Serum Institute.
She previously worked as an Independent Director at SANUWAVE Health, Inc., Director at Nycomed Hellas SA, Vice President of Corporate Alliance Management at Novo Nordisk A, Principal at H.
Lundbeck A, and Chief Operating Officer at EffRx, Inc. She also held the position of Chief Operating Officer at EffRx Pharmaceuticals SA and Vice President of International Licensing at Takeda A. Kaltoft received her graduate degree from the University of Copenhagen in 1990 and her doctorate in 1998.
She also received a graduate degree from Seattle University in 1998.
Postes actifs de Maj-Britt Kaltoft
| Sociétés | Poste | Début |
|---|---|---|
Statens Serum Institute
 Statens Serum Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2017 |
Anciens postes connus de Maj-Britt Kaltoft
| Sociétés | Poste | Fin |
|---|---|---|
| SANUWAVE HEALTH, INC. | Directeur/Membre du Conseil | 28/06/2021 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 01/01/2016 |
EffRx, Inc.
 EffRx, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Directeur des opérations | 10/06/2011 |
Nycomed Hellas SA | Directeur/Membre du Conseil | 01/01/2007 |
| H. LUNDBECK A/S | Corporate Officer/Principal | 01/01/2003 |
Formation de Maj-Britt Kaltoft
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
92
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Novo Nordisk A/S
 Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
EffRx, Inc.
EffRx, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
EffRx Pharmaceuticals SA
 EffRx Pharmaceuticals SA Pharmaceuticals: OtherHealth Technology Develops and markets drugs specializing in musculoskeletal & rare diseases | Health Technology |
Seattle University
 Seattle University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Copenhagen
 University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda A/S
 Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Finance |
Statens Serum Institute
Statens Serum Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SANUWAVE Health, Inc.
 SANUWAVE Health, Inc. Medical SpecialtiesHealth Technology Operates as a shockwave technology company using noninvasive, high energy, acoustic shockwaves for regenerative medicine and other applications | Health Technology |
Nycomed Hellas SA |
Choisissez Zonebourse 
